01
Customer first
We intend to understand downstream buyer specifications before fixing genetics, scale or facility design.
Early-stage project · North East England
Building the foundations for responsible UK cultivation.
NorthEast BioSystems is developing an engineering-led concept for controlled-environment botanical production serving regulated pharmaceutical supply chains.
About the project
An engineering-led route to regulated botanical production.
NorthEast BioSystems is exploring how a reliable UK cultivation platform can be designed around customer requirements, regulatory compliance and sound engineering from the outset.
02
Compliance by design
The regulatory model, product-transfer point and quality responsibilities are being examined before major capital is committed.
03
Engineering discipline
Facility, airflow, lighting, energy, security and production systems will be considered as one integrated operating system.
Current focus
Validating the business before building the facility.
The project is currently focused on evidence, not appearances. Each workstream is intended to reduce risk and improve the quality of the eventual investment decision.
Commercial validation
Understanding buyer requirements, target specifications, volumes, pricing and appetite for UK-grown supply.
Regulatory architecture
Defining the minimum viable licensed operating model and the practical boundary between cultivation and pharmaceutical manufacture.
Facility concept
Developing a modular, controlled-environment design with realistic energy, HVAC, security and operational assumptions.
Production model
Testing assumptions around lifecycle, batch scheduling, yield, saleable output and quality control.
Financial viability
Building conservative, base and upside scenarios centred on fully loaded production cost in pounds per gram.
Partnership development
Preparing for structured conversations with appropriately licensed downstream manufacturers, distributors and technical partners.
Project principles
A precise vision, honestly presented.
The project is deliberately early stage. Credibility will come from disciplined execution, transparent communication and validated assumptions.
Customer first
Design around genuine demand and product specifications.
Facility second
Avoid speculative construction before commercial validation.
Compliance by design
Build regulatory responsibilities into the operating model.
Evidence over hype
Separate verified facts, assumptions and future ambition.
Development roadmap
From concept to a licensed operating business.
The roadmap will evolve as commercial and regulatory evidence improves.
Phase 1
Research and feasibility
Market, regulatory, cultivation, facility and financial validation.
Phase 2
Customer engagement
Voice-of-customer interviews, specification discovery and conditional offtake discussions.
Phase 3
Operating model and design
Confirm licences, product-transfer responsibilities, site criteria and facility concept.
Phase 4
Funding and licensing
Develop the capital stack and progress formal regulatory applications.
Phase 5
Build, validate and operate
Construct, commission, validate and begin licensed supply.
Start a conversation
Early conversations can shape the project.
We welcome discussions with licensed manufacturers, distributors, pharmaceutical specialists, researchers, technology providers and regional development partners.
Email NorthEast BioSystems